Company / Shares Outstanding
Veracyte, Inc. Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
77.8M
FY2025
5-year range
58.2M / 77.8M
FY2021-FY2025
Trend
+6.2%
vs FY2024
Sector context
#92 of 165
Health Care
What the data says
At 77772678.00, Veracyte, Inc.'s shares outstanding ranks #74 of 165 in the Health Care sector. Shares Outstanding has increased for 7 consecutive years, from 33762278.00 in FY2018 to 77772678.00 in FY2025.
Based on SEC 10-K filings.
77772678.00 in FY2025 with a 5-year CAGR of +9.4%.
Increased from 71959454.00 to 77772678.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +3.0%
- 5-Year CAGR
- +9.4%
- 10-Year CAGR
- -
Sector benchmark
#74 of 165 in Health CareTop 44% of 165This company 77.8M Sector average 170.3M
▼
-54.3% below sector average
Key checks
Key Insights
- Veracyte, Inc.'s shares outstanding has grown for 7 consecutive years.
- In FY2025, shares outstanding increased 6.2% year-over-year.
- Ranks #92 out of 165 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 6.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 77.8M | +6.2% |
| FY2024 | 73.3M | +1.8% |
| FY2023 | 72.0M | +1.2% |
| FY2022 | 71.1M | +22.2% |
| FY2021 | 58.2M | +17.3% |
| FY2020 | 49.6M | +21.4% |
| FY2019 | 40.9M | +21.0% |
| FY2018 | 33.8M | +0.0% |
| FY2017 | 33.8M | +22.0% |
| FY2016 | 27.7M | +22.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026